FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Seaway Pharma Nasal Spray Original No Drip Oxymetazoline Recall

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz

Seaway Pharma Inc. · Massena, NY

Risk level
Class II
Reported by FDA
Jan 10, 2024
Recall ID
D-0214-2024
Check your lot numberHow we source this data

Summary

Seaway Pharma recalled Nasal Spray Original No Drip Oxymetazoline starting Dec 28, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0214-2024 on Jan 10, 2024. Reason: CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products. Status: Ongoing.

Why it was recalled

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Product description

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.

Lot numbers, UPCs & expiration codes

Lot # SD23032, Exp 04/30/2026

Where it was sold

MI, PA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0214-2024
Classification
Class II
Status
Ongoing
Recall initiated
Dec 28, 2023
FDA report date
Jan 10, 2024
Quantity
7,992 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Seaway Pharma Inc.

Original FDA data

Every field from FDA enforcement report D-0214-2024, exactly as published.

Show all FDA fields
City
Massena
State
NY
Status
Ongoing
Country
United States
Event ID
93708
Address
5 County Route 42
Code information
Lot # SD23032, Exp 04/30/2026
Postal code
13662-1569
Report date
Jan 10, 2024
Product type
Drugs
Recall number
D-0214-2024
Classification
Class II
Recalling firm
Seaway Pharma Inc.
Product quantity
7,992 bottles
Reason for recall
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.
Distribution pattern
MI, PA
Recall initiation date
Dec 28, 2023
Initial firm notification
Letter
Center classification date
Jan 4, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0214-2024, published Jan 10, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls